These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9602946)

  • 21. Buflomedil poisoning: a potentially life-threatening intoxication.
    Vandemergel X; Biston P; Lenearts L; Marécaux G; Daune M
    Intensive Care Med; 2000 Nov; 26(11):1713. PubMed ID: 11193288
    [No Abstract]   [Full Text] [Related]  

  • 22. Interference by carbamazepine and oxcarbazepine with serum- and urine-screening assays for tricyclic antidepressants.
    Saidinejad M; Law T; Ewald MB
    Pediatrics; 2007 Sep; 120(3):e504-9. PubMed ID: 17766494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The screening for common drugs of abuse in whole blood by means of EMIT-ETS and FPIA-ADx urine immunoassays.
    Maier RD; Erkens M; Hoenen H; Bogusz M
    Int J Legal Med; 1992; 105(2):115-9. PubMed ID: 1520635
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Fatal suicide by buflomedil poisoning].
    Cochard G; Tanguy L; Dubois A; Sizun J
    Presse Med; 1991 Nov; 20(35):1739-40. PubMed ID: 1836592
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative evaluation of five immunoassays for the analysis of alprazolam and triazolam metabolites in urine: effect of lowering the screening and GC-MS cut-off values.
    Fraser AD; Meatherall R
    J Anal Toxicol; 1996; 20(4):217-23. PubMed ID: 8835658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Reversible neurologic toxicity of buflomedil overdosage].
    Otmane-Telba M; Gury B; Paulien R; Feret J; Nouailhat F
    Presse Med; 1985 Feb; 14(5):286. PubMed ID: 3157120
    [No Abstract]   [Full Text] [Related]  

  • 27. [Myoclonic encephalopathy in a patient treated with an excessive dose of buflomedil].
    Presse Med; 1983 May; 12(23):1492. PubMed ID: 6222351
    [No Abstract]   [Full Text] [Related]  

  • 28. False-positive serum tricyclic antidepressant concentrations using fluorescence polarization immunoassay due to the presence of hydroxyzine and cetirizine.
    Dasgupta A; Wells A; Datta P
    Ther Drug Monit; 2007 Feb; 29(1):134-9. PubMed ID: 17333576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories.
    Lu NT; Taylor BG
    Forensic Sci Int; 2006 Mar; 157(2-3):106-16. PubMed ID: 15899564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quetiapine cross-reactivity with plasma tricyclic antidepressant immunoassays.
    Caravati EM; Juenke JM; Crouch BI; Anderson KT
    Ann Pharmacother; 2005 Sep; 39(9):1446-9. PubMed ID: 16046487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interference of Gemfibrozil with Roche TesTcup.
    Lewis JH
    J Anal Toxicol; 1999 Sep; 23(5):384. PubMed ID: 10488928
    [No Abstract]   [Full Text] [Related]  

  • 32. [Application of liquid chromatography coupled with mass spectrometry (LC/MS) to determine antidepressants in blood samples].
    Pufal E; Sykutera M
    Arch Med Sadowej Kryminol; 2008; 58(4):171-6. PubMed ID: 19441687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. False-positive serum tricyclic antidepressant concentrations using fluorescence polarization immunoassay due to the presence of hydroxyzine and cetirizine.
    Dasgupta A; Wells A; Datta P
    Ther Drug Monit; 2006 Oct; 28(5):662-7. PubMed ID: 17038882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interference of carbamazepine and carbamazepine 10,11-epoxide in the fluorescence polarization immunoassay for tricyclic antidepressants: estimation of the true tricyclic antidepressant concentration in the presence of carbamazepine using a mathematical model.
    Dasgupta A; McNeese C; Wells A
    Am J Clin Pathol; 2004 Mar; 121(3):418-25. PubMed ID: 15023047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin B2 interference with TDx drugs-of-abuse assays.
    Kunsman GW; Levine B; Smith ML
    J Forensic Sci; 1998 Nov; 43(6):1225-7. PubMed ID: 9846401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunoassay reagents for psychoactive drugs. Part 3. Removal of phenothiazine interferences in the quantification of tricyclic antidepressants.
    Adamczyk M; Fishpaugh JR; Harrington CA; Hartter DE; Hruska RE; Vanderbilt AS
    Ther Drug Monit; 1993 Oct; 15(5):436-9. PubMed ID: 8249051
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Assay technic for 3 tricyclic antidepressants using high performance liquid chromatography].
    Blanc M; Tran MA; Cotonat J
    Therapie; 1983; 38(1):17-20. PubMed ID: 6867996
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of high-performance liquid chromatography in clinical toxicology. II. Tricyclic antidepressants.
    Hackett LP; Dusci LJ
    Clin Toxicol; 1979; 15(1):55-61. PubMed ID: 498737
    [No Abstract]   [Full Text] [Related]  

  • 39. [Analytical problems in examination of small amounts of blood samples taken from law offenders].
    Celiński R; Kulikowska J; Albert M; Sybirska H
    Arch Med Sadowej Kryminol; 2002; 52(3):229-39. PubMed ID: 14669694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cyclobenzaprine on tricyclic antidepressant assays.
    Van Hoey NM
    Ann Pharmacother; 2005; 39(7-8):1314-7. PubMed ID: 15956237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.